Physician profile
David C Sperling
NPI 1255339420
$42,479.30
in general payments reported to CMS, 2019-2025
18 companies · $4,770 in 2025
The $4,770 reported for 2025 was more than what 85% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $3,525 · 2021: $1,009 · 2022: $2,832 · 2023: $3,167 · 2024: $11K · 2025: $4,770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,750 · Food and Beverage: $1,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,100.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,750.00 |
| Food and Beverage | $1,220.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sirtex Medical INC | $20,532.63 | 2019-2023 | Sir-Spheres Microspheres |
| Siemens Medical Solutions USA, INC. | $13,768.77 | 2021-2025 | Cios Spin |
| Merit Medical Systems INC | $6,351.04 | 2019-2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $440.00 | 2020 | |
| Trisalus Life Sciences, INC. | $354.31 | 2025 | Trinav Infusion System |
| Penumbra, INC. | $343.93 | 2019-2024 | Indigo System |
| Philips North America LLC | $172.07 | 2019 | |
| Bard Peripheral Vascular, INC. | $139.13 | 2025 | Denali Vena Cava Filter |
| Boston Scientific Corporation | $91.73 | 2021-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Terumo Medical Corporation | $69.53 | 2022-2024 | Glidesheath Slender, Azur Cx Detachable, Navicross |
| Guerbet LLC | $38.49 | 2024 | |
| Angiodynamics, INC. | $34.63 | 2019-2020 | |
| Varian Medical Systems, INC. | $31.64 | 2019 | |
| Medtronic USA, INC. | $27.78 | 2019 | |
| Glaxosmithkline, LLC. | $26.60 | 2025 | Shingrix |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dova Pharmaceuticals | $21.86 | 2019 | |
| Balt USA, LLC | $19.63 | 2022 | |
| Cordis US Corp. | $15.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Sperling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.